| Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade DK Kim, TH Yoo, DR Ryu, ZG Xu, HJ Kim, KH Choi, HY Lee, DS Han, ... Peritoneal dialysis international 24 (5), 424-432, 2004 | 271 | 2004 |
| Specific down‐regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes M Guha, ZG Xu, D Tung, L Lanting, R Natarajan The FASEB Journal 21 (12), 3355-3368, 2007 | 263 | 2007 |
| Role of the Akt/FoxO3a pathway in TGF-β1–mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease M Kato, H Yuan, ZG Xu, L Lanting, SL Li, M Wang, MCT Hu, MA Reddy, ... Journal of the American Society of Nephrology 17 (12), 3325-3335, 2006 | 214 | 2006 |
| Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells MA Reddy, SL Li, S Sahar, YS Kim, ZG Xu, L Lanting, R Natarajan Journal of Biological Chemistry 281 (19), 13685-13693, 2006 | 189 | 2006 |
| Arginase-1–dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus H Wu, Y Zhen, Z Ma, H Li, J Yu, ZG Xu, XY Wang, H Yi, YG Yang Science translational medicine 8 (331), 331ra40-331ra40, 2016 | 165 | 2016 |
| Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy J Gu, Y Cheng, H Wu, L Kong, S Wang, Z Xu, Z Zhang, Y Tan, BB Keller, ... Diabetes 66 (2), 529-542, 2017 | 158 | 2017 |
| Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 … ZG Xu, L Lanting, ND Vaziri, Z Li, L Sepassi, B Rodriguez-Iturbe, ... Circulation 111 (15), 1962-1969, 2005 | 142 | 2005 |
| Hepatocarcinogenesis in FXR−/− Mice Mimics Human HCC Progression That Operates through HNF1α Regulation of FXR Expression N Liu, Z Meng, G Lou, W Zhou, X Wang, Y Zhang, L Zhang, X Liu, Y Yen, ... Molecular endocrinology 26 (5), 775-785, 2012 | 122 | 2012 |
| Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli ZG Xu, TH Yoo, DR Ryu, HC Park, SK Ha, DS Han, SG Adler, R Natarajan, ... Kidney international 67 (3), 944-952, 2005 | 120 | 2005 |
| Role of sirtuin-1 in diabetic nephropathy W Wang, W Sun, Y Cheng, Z Xu, L Cai Journal of Molecular Medicine 97, 291-309, 2019 | 117 | 2019 |
| circLRP6 regulates high glucose‐induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells B Chen, Y Li, Y Liu, Z Xu Journal of cellular physiology 234 (11), 21249-21259, 2019 | 114 | 2019 |
| Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy Y Cheng, J Zhang, W Guo, F Li, W Sun, J Chen, C Zhang, X Lu, Y Tan, ... Free Radical Biology and Medicine 93, 94-109, 2016 | 90 | 2016 |
| Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes H Yuan, L Lanting, ZG Xu, SL Li, P Swiderski, S Putta, M Jonnalagadda, ... American Journal of Physiology-Renal Physiology 295 (2), F605-F617, 2008 | 79 | 2008 |
| Novel interactions between TGF-β1 actions and the 12/15-lipoxygenase pathway in mesangial cells YS Kim, ZG Xu, MA Reddy, SL Li, L Lanting, K Sharma, SG Adler, ... Journal of the American Society of Nephrology 16 (2), 352-362, 2005 | 78 | 2005 |
| Effect of losartan and amlodipine on proteinuria and transforming growth factor‐β1 in patients with IgA nephropathy HC Park, ZG Xu, S Choi, YS Goo, SW Kang, KH Choi, SK Ha, HY Lee, ... Nephrology Dialysis Transplantation 18 (6), 1115-1121, 2003 | 77 | 2003 |
| Renal protective effect of sirtuin 1 Y Dong, N Liu, Z Xiao, T Sun, S Wu, W Sun, Z Xu, H Yuan Journal of Diabetes Research 2014 (1), 843786, 2014 | 70 | 2014 |
| Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy ZG Xu, SL Li, L Lanting, YS Kim, N Shanmugam, MA Reddy, R Natarajan Kidney international 69 (3), 512-519, 2006 | 69 | 2006 |
| Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity ND Vaziri, ZG Xu, A Shahkarami, KT Huang, B Rodruguez-Iturbe, ... Kidney international 68 (6), 2787-2793, 2005 | 67 | 2005 |
| Epigenetic histone modifications involved in profibrotic gene regulation by 12/15-lipoxygenase and its oxidized lipid products in diabetic nephropathy H Yuan, MA Reddy, S Deshpande, Y Jia, JT Park, LL Lanting, W Jin, ... Antioxidants & redox signaling 24 (7), 361-375, 2016 | 63 | 2016 |
| High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells ZG Xu, KS Kim, HC Park, KH Choi, HY Lee, DS Han, SW Kang Kidney international 63 (3), 958-968, 2003 | 59 | 2003 |
